Oct 8, 2019

Akcea and Pfizer Inc. Announce Licensing Agreement for investigative antisense therapy AKCEA-ANGPTL3-L(Rx) - GlobeNewswire

  1. Akcea and Pfizer Inc. Announce Licensing Agreement for investigative antisense therapy AKCEA-ANGPTL3-L(Rx)  GlobeNewswire
  2. After leadership shuffle, Akcea hands heart drug to Pfizer for $250M  FierceBiotech
  3. Here's Why Akcea Therapeutics Jumped 30% Today  The Motley Fool
  4. Pfizer to Develop Akcea/Ionis Antisense Candidate for Up to $1.5B  Genetic Engineering & Biotechnology News
  5. What Happened in the Stock Market Today  Motley Fool
  6. View full coverage on Google News


from Top stories - Google News https://ift.tt/2OqQd6T
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)